Every dollar participants fundraise directly supports groundbreaking science at Fred Hutch, thanks to our generous sponsors and supporters.
$9.2M
Raised to support Fred Hutch
5,057
Participants
475
Teams
948
Volunteers
1,089
Fred Hutch and UW Medicine employee participants
24,025
Donors
29,790
Donations received
43
Sponsors
How We Participated
We rode, walked, ran, rolled, cheered — and fundraised for world-changing cancer research. Here’s how Obliteriders took part this year.
100-mile Ride
8%
50-mile Ride
11%
25-mile Ride
8%
5K Walk/Run
62%
Virtual
11%
Where We Came From
Obliteriders took action from around the world!
Participants from 39 U.S. States
Participants from 7 Countries
Across 4 Continents
Australia
Canada
Germany
Japan
Netherlands
United Kingdom
United States
Leaderboards
Above and beyond! In 2025, these leading participants and teams shared Fred Hutch’s mission and inspired thousands of donors to support scientific discovery.
As of October 28, 2025.
Top 5 Individuals
Most Raised
| NAME | AMOUNT |
| Nancy Greenwood Vehrs | $240,000 |
| Bob Ratliffe | $206,250 |
| Molly Nordstrom Sloan | $165,500 |
| Marka Jenkins | $67,100 |
| Darrell Rodgers | $56,600 |
Top 5 Corporate Teams
Most Raised
| NAME | AMOUNT |
| Silver Creek Capital Management | $254,180 |
| Lewis & Friends | $202,500 |
| Cascade Bicycle Studio / #WeRideWhy | $141,619 |
| Team Sahsen | $123,137 |
| Compass Construction | $121,780 |
Top 5 Fred Hutch & UW Medicine Staff Teams
Most Raised
| NAME | AMOUNT |
| Skin in the Game | $54,965 |
| Heart and Soles | $46,646 |
| Fizards Forever | $41,691 |
| UW TIME Lab | $40,600 |
| Team Hollandaise | $30,820 |
Top 5 Friends & Family Teams
Most Raised
| NAME | AMOUNT |
| Village People | $302,620 |
| Orange Lanterns | $243,670 |
| LFP Cancer Crushers | $88,876 |
| Team Orange | $83,232 |
| Smack Down Cancer | $64,173 |
Top 5 Friends & Family Teams
Most Participants
| NAME | NUMBER |
| Crushin' Cancer | 60 |
| LFP Cancer Crushers | 54 |
| Team Wellesley | 47 |
| Hana Jacob | 42 |
| Geno Rosellini | Giovanni Gold | 40 |
Top 5 Corporate Teams
Most Participants
| NAME | NUMBER |
| Edward Jones — Market 21 | 158 |
| Team Sahsen | 80 |
| Lewis & Friends | 68 |
| Adaptive Biotechnologies | 67 |
| Silver Creek Capital Management | 56 |
Our Impact
Obliteride fuels the future of cancer research and care.
Every participant-raised dollar fuels groundbreaking discovery at Fred Hutch, thanks to our generous event sponsors and supporters. Our fundraising puts our passion to work. In every lab, clinic, and program we support. For every person and family experiencing cancer. To advance prevention, detection, treatment, and cures.
Because of Obliteride:
There are immunotherapies for more cancers
Fred Hutch researchers are harnessing the immune system to stop prostate, pancreatic, skin, blood, and kidney cancers — with more on the horizon.
Big data = big insights
We’re using new tools to advance diagnosis, improve treatments, and understand why some cancers resist therapies.
Prevention is possible
Fred Hutch scientists have identified lifestyle and environmental factors that increase risks — so we can help people take action.
We’re advancing precision oncology
Fundamental research from our labs is unlocking new personalized treatments.
Personal and Powerful
In 2025, thousands of Obliteriders chose to fundraise for the specific disease areas, programs, faculty, or clinicians that have touched their lives. Others partnered with Fred Hutch by supporting our general fund for cancer research greatest need.
28
Disease areas supported
92
Faculty and clinicians supported
28
Programs and specialties supported
Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia (AML)
Bladder-urologic cancer
Breast cancer
Cervical cancer
Chronic myeloid leukemia (CML)
Colon/colorectal cancer
COVID-19 virus and vaccine research
Esophageal cancer
Gastrointestinal cancers
Gynecologic cancers
Hematologic cancers
HIV virus and vaccine research
Infectious disease research
Kidney/renal cancer
Leukemia
Lung cancer
Lymphoma
Melanoma
Merkel cell carcinoma
Multiple myeloma
Neuroendocrine tumors
Neurologic cancers
Ovarian cancer
Pancreatic cancers
Prostate cancer
Sarcoma
Thoracic, head, and neck cancers
Garnet L. Anderson, PhD
Smith Apisarnthanarax, MD
Christina Baik, MD, PhD
Alice H. Berger, PhD
Irwin D. Bernstein, MD
Shailender Bhatia, MD
Marie Bleakley, MD, PhD, MMSC
Michael Boeckh, MD, PhD
Jim Boonyaratanakornkit, MD, PhD
Phil Bradley, PhD
Jonathan B. Bricker, PhD
Melody G. Campbell, PhD
Ryan Cassaday, MD
Aude Chapuis, MD
Delphine Chen, MD
Eric Chow, MD, MPH
Stacey Cohen, MD
Lillian B. Cohn, PhD
Laura Connelly-Smith, MBBCh, DM
Lawrence Corey, MD
Nancy Davidson, MD
Neelendu Dey, MD
Madhav Dhodapkar, MBBS
Jarrod A. Dudakov, PhD
Bob Eisenman, PhD
Ralph Ermoian, MD
R. Failor, MD
Min Fang, MD, PhD
Meghan Flanagan, MD, MPH
Lawrence Fong, MD
David Fredricks, MD
Nicholas Giustini, MD
Ajay Gopal, MD, FACP
William Grady, MD
Philip Greenberg, MD
Heather Greenlee, ND, PhD, MPH
Gavin Ha, PhD
Evan Hall, MD, MPhil
Anna Halpern, MD
Paul Hendrie, MD, PhD
Joshua Hill, MD
Eric C. Holland, MD, PhD
Hanna Hunter, MD
Sara Hurvitz, MD, FACP
Rachel Issaka, MD, MAS
Sioban Keel, MD
Edward Kim, MD
Mukta Krane, MD
Sita Kugel, PhD
Mary Kwok, MD
Johanna W. Lampe, PhD, RD
Stanley C. Lee, PhD
Catherine Lee, MD, MsC
Stephanie Lee, MD, MPH
Hannah Linden, MD, FACP
Ryan Lynch, MD
Emily Marchiano, MD
Jared Mayers, MD, PhD
Soheil Meshinchi, MD, PhD
Behnam Nabet, PhD
Rosa Nadal Rios, MD, PhD
Peter Nelson, MD
Paul Nghiem, MD, PhD
Yaw Nyame, MD, MBA
Vivian Oehler, MD
Johnnie Orozco, MD, PhD
Katrina Ortblad, ScD, MPH
Folashade Otegbeye, MBChB, MPH
Hans-Peter Kiem, MD, PhD
Amanda I. Phipps, PhD, MPH
Venu Pillarisetty, MD
Cristina Rodriguez, MD
Michael Schweizer, MD
Mazyar Shadman, MD, MPH
Jonathan Sham, MD
Veena Shankaran, MD, MS
Jeremy Sharib, MD
Megan Shen, PhD
Derek Stirewalt, MD
Roland Strong, PhD
Lucas B. Sullivan, PhD
Elizabeth Swisher, MD
Lynne P. Taylor, MD, FAAN, FANA
Monica Thakar, MD
Brian Till, MD
Matthew Triplette, MD, MPH
Joshua Veatch, MD, PhD
Edus Warren, MD, PhD
Jonathan L. Wright, MD, MS, FACS
Cecilia Yeung, MD
Todd Yezefski, MD
David Zhen, MD
Basic science
Breast surgery
Cancer prevention and early detection
Center for Innovations in Cancer & Transplant
Center for Metastatic Research eXcellence (MET-X)
Cook for Your Life
Cord blood research
Data Science Lab (DaSL)
Emerging technologies and
state-of-the-art equipment
Evergreen Fund
Health disparities research
HSV gene therapy
Hutchinson Institute for Cancer
Outcomes Research (HICOR)
Immunotherapy
Institute for Prostate Cancer Research (IPCR)
Long-term follow-up
Nursing Excellence Fund
Office of Community Outreach & Engagement
Palliative Care Program
Patient and Family Assistance Fund
Patient housing
Patient Navigator Program
Patient supportive services
Postbaccalaureate Scholar Program
Radiation oncology
Science education
Science Education Partnership (SEP)
Survivorship Program
Researcher and Program Highlights
Fred Hutch researchers and programs are advancing science and changing lives in Seattle and around the world. Here are three examples.
Researcher: Elizabeth Swisher, MD
Professor, physician, and researcher; Fred Hutch and UW Medicine
Torkelson Family Endowed Chair, Fred Hutch
With support from Obliteride and other donors, Dr. Swisher is discovering the genetic risk factors of gynecologic cancers; using precision oncology approaches to provide unique treatments for each patient and cancer; and saving lives. For example, she and her colleagues identified the connection between hereditary ovarian cancer and gene mutations beyond BRCA1&2, unlocking critical screening for people at high risk. “I love the fact that I can do research that improves our understanding of the diseases I treat and then translate those discoveries into benefits for patients on a day-to-day basis,” says Dr. Swisher.
Programs: Education and Training
Our future relies on young scientists. With support from Obliteride, Fred Hutch is preparing new generations.
Obliteride funding helps Fred Hutch strengthen the pipeline that makes future discovery possible by training and mentoring rising scientists. Right now, more than 400 graduate students and postdoctoral fellows are supporting discoveries in our labs. Each year, we invite more than 200 high school and college students to participate in research through our education programs. And our Science Education Partnership has paired more than 600 teachers with scientists and reached tens of thousands of students across Washington state and more nationwide.
Researcher: Folashade Otegbeye, MBChB, MPH
Associate Professor, Fred Hutch and UW Medicine
Facility Director, Therapeutic Products Program, Fred Hutch
Fleischauer Family Endowed Chair in Cell and Gene Therapy Translation
Once treatments are developed, it takes special expertise to ensure they reach patients. With support from Obliteride and other donors, Dr. Otegbeye makes it happen. As director of our Therapeutic Products shared resource, she helps colleagues translate immunotherapy innovations into clinical products, such as genetically modified blood cells for immunotherapy. As a researcher, she studies transplant and immune cell therapy to improve patient care. “We have a lot of ongoing, frequent interactions with patients and their family members or caregivers,” said Dr. Otegbeye. “I’ve always been inspired, and touched, by those relationships."
“This is an incredible moment in cancer and infectious disease research. We’ve made tremendous progress over the past few decades in partnership with our dedicated supporters — and that progress only makes me more excited for what’s yet to come.”
— Thomas J. Lynch, Jr., MD, Fred Hutch President and Director and holder of the Raisbeck Endowed Chair
About Fred Hutch
Fred Hutch Cancer Center unites individualized care and advanced research to provide the latest cancer treatment options while accelerating discoveries that prevent, treat, and cure cancer and infectious diseases worldwide.
Based in Seattle, Fred Hutch is an independent, nonprofit organization and the only National Cancer Institute-designated cancer center in Washington. We have earned a global reputation for our track record of innovation in cancer, infectious disease and basic research, including important advances in bone marrow transplantation, immunotherapy, HIV/AIDS prevention, and COVID-19 vaccines. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy, and related services. Fred Hutch also serves as UW Medicine’s cancer program. Learn more about Fred Hutch.
As we mark our 50th Anniversary in 2025, Fred Hutch is looking beyond what’s possible today to a new era of discovery. With your partnership, our Campaign for Fred Hutch will transform the pace and scale of innovation so we can redefine cancer and infectious disease for generations to come.
Who We Are
We’re cyclists, walkers, runners, virtual participants and volunteers; individuals and teams; people who have experienced cancer and their families; dedicated event sponsors and supporters; and all those passionate about cancer cures. Get to know a few members of our fundraising community.
Connection and Commitment
“When I was diagnosed with throat cancer, I had no idea what lay ahead,” said Obliterider, educator, and jazz musician Chris Bruya. “Would I survive? Would I play the trumpet again?” Now 12 years in remission, Chris supports and educates others. “Because of Fred Hutch research, we know that all cervical cancers, and many cancers like mine, are linked to the human papillomavirus, or HPV,” said Chris. “That work led to a vaccine for HPV. I Obliteride to fuel more research, improve prevention and treatment, and give patients more options.”
Love and Science
When Lacy Fehrenbach was diagnosed with stage III lung cancer in 2024, she had no known risk factors. “It upended life for me, my family, and my friends,” said Lacy, “but we made a choice to face it with determination and optimism.” Now, she said. “I’m living fully because of love, Fred Hutch’s excellent care — and science.” Because of research, lung cancer survival rates have improved by 26% over the past five years. “The dollars we raise will bring us closer to earlier detection, better treatments, and ultimately, to preventing cancer.”
Light in Every Day
Danielle Bigler walked the 5K with loved ones — including her youngest son, Peter. At 20 weeks pregnant, Danielle was diagnosed with acute lymphoblastic leukemia. After care to help her safely deliver Peter, she began treatment at Fred Hutch, including a bone marrow transplant and immunotherapy.
“New therapies save lives, and they certainly saved mine,” said Danielle. “Community inspires me to find light in moments every day. To heal, and not just survive, but to live. Obliteriders fuel urgently needed advances in treatment and care.”
Building Community
“The thing that makes Obliteride amazing is the community it creates,” said volunteer Cassie Withrow. “I started helping through my company, GLY Construction. We have been a sponsor for several years, and it’s an amazing way to give back to the community we live and work in.” This year, Cassie’s participation was personal. "My mom is undergoing cancer treatment, and Fred Hutch is the one place near us that has specialists learning about her form of cancer. I want to do everything I can to give back: for my family and for families across the world."
Riding for Cures
“Things are possible today that we could not have imagined years ago,” said Glenn Dalby, who was treated for large diffuse B-cell lymphoma at Fred Hutch. Glenn, his wife Diana, and his team TwoPointZero, Obliteride to commemorate his successful stem cell transplant, honor caregivers, and fuel discoveries.
“I’m a direct beneficiary of research,” said Glenn, “but options weren’t available when my father and Diana’s mother passed from cancer. We ride so that, in the future, there are treatments and even cures for every person and every cancer.”
Miles, Mountains, Mission
“My 2025 virtual Obliteride was a full-day mountain biking trip in Washington state,” said 7-year participant Keith Michel. “I started up a beautiful mountain trail and descended to a crystal lake. Later, as I rode the ridgeline, I reflected on why I Obliteride. I’m motivated by being part of the Fred Hutch mission. Fundraising, spreading awareness, and supporting this important cause — all while spending the day outdoors pursuing my passion — is powerful. I’m honored to be part of this community.”
“This was my third Obliteride, and I have been doing it because our patients deserve it and because it’s a privilege to be here every year on behalf of my colleagues and our researchers.”
— Justin Speyer, Advanced Registered Nurse Practitioner, Fred Hutch
United for Cures
One community, one goal: Fuel research that helps cure cancer faster.
13 Years Strong
In 2013, a few hundred cyclists started a movement to help Fred Hutch improve cancer prevention, detection, treatment, and cures. More than a decade later, we’re a community of thousands united by the unshakable knowledge that, together, we are advancing scientific discovery and improving lives.
$67M+
Raised to support Fred Hutch
40,000+
Participants
209,000+
Donors
7,000+
Volunteers
From the Start! Our 13-Year Participants Shine.
For more than a decade, these amazing leaders have fundraised, sweat, and inspired thousands to add their voice (and support) to Fred Hutch’s mission.
Patricia Aguilar
Geoffrey Anderson
John Barton
Greg Berkman
Ruth Berkman
Tom Blumenstein
Steve Brooks
Carolyn Callaghan
Evanna Charlot
Larry Corey
James Crutcher
David Dapelo
Bob Davis
Julie di Furia
Jeff Dossett
Natalie Duerkopp
Kevin Eckert
Frederick Fiene
Kristin Funston
Brad Glaberson
Nancy Greenwood Vehrs
Linda Helm
David Ignacio
Reid Jones
Brent Knudson
Amy Lavin
Kim Lengle
Rafferty Lengle
Jennifer Lester
Laura McQueen
Patrick McQueen
Rex Miller
Beth Mueller
Peter Nelson
Chris Nichols
Tristan Osborn
Owen Pearson
Mary Pettinger
Susie Plummer
Jerald Radich
Chad Robins
Darren Rozendaal
Michael Rubin
John Rumpeltes
Jai Russell
Pete Schneider
Alan Schulkin
Susan Schulkin
Steve Schwartz
Stuart Sloan
Carey Smith
David Thompson
Christopher Varley
Patti Varley
Jeff Vehrs
Donald Wang
Sandy Ward
Margaret Weiland
Karin Yarbrough
Adam Zivin
“I ride with Obliteride to cure cancer faster. But finding cures isn’t enough. Ensuring they are accessible to all, regardless of background, is just as important. Obliteride is my way to stand up for science that benefits everyone.”
— David Ignacio, 13-year Obliterider
$1 Million Teams
Over 13 years, these teams have raised $1 million+ (and counting!) to support critical advances at Fred Hutch. As of October 28, 2025.
$1,688,437
Village People
$1,630,382
Lewis & Friends
$1,421,163
Microsoft & Friends
$1,183,397
Amazon
$1,027,140
Adaptive Biotechnologies
FOUNDING SPONSOR
LEAD OUT SPONSOR
VOLUNTEER SPONSOR
CENTURY SPONSOR
BREAK AWAY SPONSORS
DYNAMO SPONSORS
CADENCE SPONSORS
AV Factory
Biolife Solutions
Lease Crutcher Lewis
Window Nation
REST STOP SPONSORS
NBBJ
Nucor Steel Seattle
Prime Electric
Skanska
UMC
CLINK SPONSORS
Alaska Airlines
Alki Marine Lumber
Compass Construction
Copiers Northwest
La Roche-Posay, L’Oreal USA
Thermo Fisher Scientific
IN-KIND DONORS
Athletic Brewing Company
Custom Interiors
Georgetown Brewing Co.
Green Latrine
HIDEF Physical Therapy
Leatherback Printing
Stoup Brewing
Talking Rain
Thorntail Hard Agave